Frontiers Gut Microbiota Dependent Marker TMAO in Promoting Cardiovascular Disease: Inflammation Mechanism, Clinical Prognostic, and Potential as a Therapeutic Target Gut microbe derived metabolite trimethylamine N oxide activates PERK to drive fibrogenic mesenchymal differentiation: iScience Simultaneous quantification of trimethylamine oxide and its precursors from gut microbial metabolic pathway View of The origin of trimethylamine N oxide (TMAO) and its role in development of atherosclerosis Journal of Food Bioactives